Yuichi Shinkoda

A phase <scp>III</scp> clinical trial of a mixture agent of plasma‐derived factor <scp>VII</scp>a and factor X (<scp>MC</scp>710) in haemophilia patients with inhibitors

Yuichi Shinkoda, Akira Shirahata, Katsuyuki Fukutake et al. · Haemophilia · 2016 · 28 citations

Rhabdomyosarcoma masquerading as acute leukemia

Yuichi Shinkoda, Yoshihisa Nagatoshi, Reiji Fukano et al. · Pediatric Blood & Cancer · 2008 · 22 citations

Response of heavily treated and relapsed hepatoblastoma in the transplanted liver to single‐agent therapy with irinotecan

Osamu Ijichi, Shuji Ishikawa, Yuichi Shinkoda et al. · Pediatric Transplantation · 2006 · 20 citations

Calcineurin‐inhibitor‐induced pain syndrome after a second allogeneic bone marrow transplantation for a child with aplastic anemia

Takuro Nishikawa, Yasuhiro Okamoto, Takayuki Tanabe et al. · Pediatric Transplantation · 2008 · 17 citations

Hematological Malignancy, Transplantation, Bone Marrow Failure +13

Trough level monitoring of intravenous busulfan to estimate the area under the plasma drug concentration–time curve in pediatric hematopoietic stem cell transplant recipients

Erika Watanabe, Takuro Nishikawa, Kazuro Ikawa et al. · International Journal of Hematology · 2015 · 15 citations

Intravenous Busulfan, Therapeutic Drug Monitoring, Trough Level Monitoring +9